The total doses administered now stand at 24.8 million
coronavirus1 day ago
Japan has approved the Covid-19 pill developed by US pharmaceutical company Merck & Co. for use beginning next week, the Japanese health minister said Friday.
Health Minister Shigeyuki Goto told reporters that a ministry drug panel authorized Merck’s molnupiravir under a fast-track process and the drug will be shipped to hospitals and pharmacies beginning next week.
ALSO READ:
It’s one of two medications for treating Covid-19 that Japan has secured. Prime Minister Fumio Kishida said the country is procuring 1.6 million doses from Merck.
Japan has also arranged for a shipment of 2 million doses of a Covid-19 pill made by Pfizer that hasn’t yet received approval for use in the country.
Until recently, Japan largely kept out coronavirus infections involving the new omicron variant by enforcing stringent border controls. The first known locally transmitted cases were reported in Osaka on Wednesday.
More cases were reported Friday in Osaka and neighbouring Kyoto, while Tokyo reported its first community-acquired omicron case.
The total doses administered now stand at 24.8 million
coronavirus1 day ago
Over 158.9 million PCR tests have been conducted in the country so far
coronavirus2 days ago
The city has been locked-down for more than six weeks in its battle to contain spread of the virus
coronavirus2 days ago
The country has no Covid vaccines, antiviral treatment drugs or mass-testing capacity
coronavirus2 days ago
The isolated country announced 21 new "fever" deaths on Saturday
coronavirus2 days ago
The total doses administered now stand at 24.8 million
coronavirus2 days ago
Over 158.6 million PCR tests have been conducted in the country so far
coronavirus3 days ago
Ardern will be required to isolate until the morning of May 21, undertaking what duties she can remotely
coronavirus3 days ago